Bristol-Myers Up Big After Drug Study Stopped Early By: Benzinga via Benzinga April 17, 2015 at 10:23 AM EDT Bristol-Myers Squibb Co (NYSE: BMY)was more than 3 percent higher in early trading after the company announced that Phase III ... Read More >> Related Stocks: Bristol-Myers Squibb